4 Biotech Stocks To Add To Your October 2021 Watchlist
In good times and bad, people and investors alike often turn to the health care industry. In particular, biotech stocks remain viable plays in the stock market today, nonetheless. For starters, investors appear to be breathing a sigh of relief thanks to the latest update on the U.S government’s debt issue. According to Senate Majority Leader Chuck Schumer, Congress has “reached an agreement to extend the debt ceiling through early December.” While this deals with one of the nation’s issues, there is still the ongoing pandemic to consider. This would be where biotech stocks among other health care industries come into play.
Namely, companies like Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) continue to play crucial roles in combating the pandemic. In fact, Pfizer is now asking the U.S. Food and Drug Administration (FDA) to greenlight its vaccine for kids ages 5 to 11.
The post 4 Biotech To Watch As Pfizer Seeks FDA Approval For Child Vaccines appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.